Features

The Evolution of a Tumor Engineer

Needham's synthetic fat globules smuggle drugs into a tumor

May 12th, 2008

By Monte Basgall

email | print | digg | del.icio.us | slashdot


return to story

Letters to the Editor (3 Responses)

  1. Rhonda Dillard Says:
    May 20th, 2008 at 9:33 am

    Are there specific tumor types that can be irradicated by these miniscule little target seekers. I have recurrent small cell lung cancer that has mets to the liver and bone?

  2. Legod Aat Says:
    July 15th, 2008 at 10:08 pm

    This article, while wonderful, makes it sound like this is a far off technology. Celsion Corp. (www.celsion.com NASDAQ: CLSN) has gained open label status for their Recurrant Chest Wall Breast Cancer study AND full FDA Special Protocal Assessment for liver cancer by putting doxorubicin in these LTSL’s. They have already had SEVERAL patients walk away with “complete clinical response” which is what we folks without PhD’s or MD’s call “cured.” Thank God for Dr. Needham, and thank God for Celsion.

  3. carol bigley Says:
    July 18th, 2008 at 9:12 pm

    can this be done with a tumor on the liver not inside